5 | GlucocorticoidsIBA
11/2010
-
02/2005 |
4 | Tyrosine Kinase InhibitorsIBA
08/2020
-
02/2009 |
3 | LigandsIBA
01/2022
-
03/2009 |
3 | Imatinib Mesylate (Gleevec)FDA Link
12/2020
-
04/2008 |
2 | Complement System Proteins (Complement)IBA
01/2022
-
10/2010 |
2 | Factor VIII (Coagulation Factor VIII)IBA
01/2021
-
01/2016 |
2 | Biomarkers (Surrogate Marker)IBA
01/2020
-
05/2019 |
2 | Dasatinib (BMS 354825)FDA Link
01/2016
-
02/2009 |
2 | nilotinibFDA Link
01/2016
-
02/2009 |
2 | Peptides (Polypeptides)IBA
01/2014
-
09/2013 |
2 | Pharmaceutical PreparationsIBA
01/2012
-
03/2005 |
2 | Proteins (Proteins, Gene)FDA Link
01/2012
-
11/2009 |
2 | Glucose (Dextrose)FDA LinkGeneric
10/2011
-
04/2008 |
2 | ThymidineIBA
09/2009
-
09/2008 |
2 | AndrogensIBA
10/2004
-
04/2002 |
1 | Streptomycin (Streptomycin Sulfate)FDA Link
07/2022 |
1 | Amine Oxidase (Copper-Containing)IBA
07/2022 |
1 | LipopolysaccharidesIBA
07/2022 |
1 | AlarminsIBA
03/2022 |
1 | tasquinimodIBA
03/2022 |
1 | ruxolitinibIBA
03/2022 |
1 | N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA
03/2022 |
1 | 11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA
03/2022 |
1 | Janus Kinase InhibitorsIBA
03/2022 |
1 | COVID-19 VaccinesIBA
03/2022 |
1 | InterferonsIBA
03/2022 |
1 | B7-H1 AntigenIBA
01/2022 |
1 | Coloring Agents (Dyes)IBA
08/2021 |
1 | PolymersIBA
06/2021 |
1 | Carbon Fiber (Grafil)IBA
06/2021 |
1 | MetalsIBA
06/2021 |
1 | carbon fiber reinforced plastic (carbon-fibre reinforced plastic)IBA
06/2021 |
1 | N'-formylkynurenineIBA
01/2021 |
1 | EnzymesIBA
01/2021 |
1 | KynurenineIBA
01/2021 |
1 | Tryptophan (L-Tryptophan)FDA Link
01/2021 |
1 | Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
01/2021 |
1 | Small Cytoplasmic RNAIBA
01/2021 |
1 | Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
03/2017 |
1 | HLA-C Antigens (HLA-C)IBA
03/2017 |
1 | Opioid Receptors (Opioid Receptor)IBA
01/2016 |
1 | GoldIBA
01/2016 |
1 | Neurotransmitter Agents (Neurotransmitter)IBA
01/2016 |
1 | Naloxone (Narcan)FDA LinkGeneric
01/2016 |
1 | von Willebrand FactorIBA
01/2016 |
1 | AnticoagulantsIBA
01/2016 |
1 | ponatinibIBA
01/2016 |
1 | ATP-Binding Cassette Transporters (ABC Transporters)IBA
08/2014 |